The alopecia treatment market holds immense growth potential owing to the
rising cases of alopecia disorders worldwide. The market consists of various
treatment options for alopecia such as topical and oral therapeutic drugs, hair
transplant services, low-level laser therapy, and vitamin supplements that aid
in hair regrowth. These treatment options facilitate hair regrowth by
controlling excess hair fall and stimulating existing hair follicles.
Global alopecia
treatment market is estimated to be valued at US$ 9.65 Bn in 2023, and is
expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).
Key Takeaways
Key players operating in the alopecia treatment market are Johnson &
Johnson Services, Inc., Merck & Co. Inc., Alpecin, Cipla Inc., Viviscal,
and Kirkland Signature. These players are adopting several organic and
inorganic growth strategies such as new product launches, acquisitions, and
collaborations to strengthen their market presence.
The rising awareness about hair loss treatment and
Alopecia
Treatment Market Growth preference for non-surgical treatment options present
lucrative opportunities in the market. Many companies are investing in R&D
to develop innovative products for alopecia with fewer side effects.
The alopecia treatment market is expanding globally, especially in Asia Pacific
and Latin America, due to increasing disposable incomes, medical tourism, and
growing per capita healthcare expenditure in emerging economies of these
regions.
Market Drivers
The increasing prevalence of alopecia disorders due to genetic predisposition,
autoimmune diseases, stress, and harsh hairstyling practices are majorly
driving the alopecia treatment market. As per recent studies, alopecia affects
over 100 million people globally each year. The growing awareness about various
treatment options available for alopecia is further fueling the market growth.
PEST Analysis
Political: Government regulations on drug approvals and new treatment approvals
impacts the market. Changes in regulations can enable or restrict new
therapies.
Economic: Rising disposable incomes and growing healthcare spending is enabling
people to spend more on treatment and medications for alopecia. High treatment
and medication costs can negatively impact the market.
Social: Growing social acceptance of hair loss and treatments for the same is
boosting the market. However, some stigmas around hair loss still persist in
certain cultures and communities.
Technological: Advancements in stem cell therapy, laser therapy and other
treatment methods are fueling market growth. Developments in drug R&D is helping
introduce newer and more effective treatment options. Continued technological
innovations will drive future market opportunities.
Geographical Concentration
The North American region accounted for the largest share of the global
alopecia treatment market in terms of value. This can be attributed to growing
hair transplants, favorable reimbursement scenarios and a high rate of hair
loss among the population in the US and Canada. The region will continue
dominating the market owing to ongoing technological advancements and robust
healthcare infrastructure.
Fastest Growing Region
The Asia Pacific region is projected to witness the highest growth over the
forecast period. Increasing disposable incomes, growing beauty consciousness
and rising medical tourism are driving the market in the developing Asian
countries. A rapidly emerging middle class and aging population make the region
an attractive market for alopecia treatment manufacturers in the coming years.
Get More
Insights on- Alopecia
Treatment Market
Discover the
Report for More Insights, Tailored to Your Language:
About
Author:
Money
Singh is a seasoned
content writer with over four years of experience in the market research
sector. Her expertise spans various industries, including food and beverages,
biotechnology, chemical and materials, defense and aerospace, consumer goods,
etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
Post a Comment